Hospitals seek to intervene in J&J lawsuit against HHS to protect valuable drug discounts.

Hospitals are seeking to intervene in a lawsuit by Johnson & Johnson against the government over changes to a drug discount program called 340B. J&J wants to give hospitals rebates instead of upfront discounts on certain drugs, but hospitals and the government argue this is illegal. The legal battle highlights ongoing tensions between drugmakers and hospitals over the 340B program, with potential financial implications for safety-net hospitals and patient care initiatives. The outcome of these lawsuits could have significant impacts on how drug discounts are distributed and managed in the healthcare industry. [Extracted from the article]